"10.1371_journal.pone.0010952","plos one","2010-06-03T00:00:00Z","Max Lataillade; Jennifer Chiarella; Rong Yang; Steven Schnittman; Victoria Wirtz; Jonathan Uy; Daniel Seekins; Mark Krystal; Marco Mancini; Donnie McGrath; Birgitte Simen; Michael Egholm; Michael Kozal","Global Development and Medical Affairs, Bristol-Myers Squibb, Wallingford, Connecticut, United States of America; Yale University School of Medicine and Veterans Affairs Connecticut Healthcare System, New Haven, Connecticut, United States of America; 454 Life Sciences, a Roche company, Branford, Connecticut, United States of America","Conceived and designed the experiments: ML M. Kozal. Performed the experiments: JC BS M. Kozal. Analyzed the data: ML JC RY SS VW BS M. Kozal. Contributed reagents/materials/analysis tools: SS JU DS MK MM DM BS ME MK. Wrote the paper: ML RY SS VW JU DS MK MM DM MK.","MJK is the local primary investigator on HIV therapy studies sponsored by Merck, Pfizer, Gilead, Abbott and Bristol-Myers Squibb. MJK receives laboratory research support from Virco and Bristol-Myers Squibb. MJK receives royalties from a patent owned by Stanford University for some HIV diagnostic tests. BS and ME are employees of 454 Life Sciences/Roche. ML, RY, SS, VW, JU, DS, MK, MM, and DM are employees of Bristol-Myers Squibb. The funding of this study by Bristol Myers Squibb does not alter adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2010","06","Max Lataillade","ML",13,TRUE,2,3,7,9,TRUE,TRUE,FALSE,0,NA,FALSE
